These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8104465)
1. Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine. Bohn M; Bohn G; Blaschke G Int J Legal Med; 1993; 106(1):19-23. PubMed ID: 8104465 [TBL] [Abstract][Full Text] [Related]
2. A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis. Renton RJ; Cowie JS; Oon MC Forensic Sci Int; 1993 Aug; 60(3):189-202. PubMed ID: 7901132 [TBL] [Abstract][Full Text] [Related]
3. [Studies on the identification of psychotropic substances (VII). Preparation and various analytical data of standard references of some hallucinogens, 3,4-methylenedioxyamphetamine (MDA), 3,4- methylenedioxymethamphetamine (MDMA) and 5-methoxy-3,4- methylenedioxyamphetamine (MMDA)]. Shimamine M; Takahashi K; Nakahara Y Eisei Shikenjo Hokoku; 1990; (108):118-25. PubMed ID: 1364339 [TBL] [Abstract][Full Text] [Related]
4. [Contamination in illegal amphetamine. Contaminants resulting from the synthesis of 3,4-(methylenedioxy)amphetamine (MDA) via condensation between nitroethane and piperonal]. Verweij AM; Sprong AG Arch Kriminol; 1992; 190(1-2):24-8. PubMed ID: 1417396 [TBL] [Abstract][Full Text] [Related]
5. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy). Carter JF; Titterton aE; Murray M; Sleeman R Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919 [TBL] [Abstract][Full Text] [Related]
6. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method. Visser HA; Visser-van Leeuwen M; Huizer H Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020 [TBL] [Abstract][Full Text] [Related]
7. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets. Furnari C; Ottaviano V; Rosati F; Tondi V Forensic Sci Int; 1998 Mar; 92(1):49-58. PubMed ID: 9627975 [TBL] [Abstract][Full Text] [Related]
8. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Poklis A; Fitzgerald RL; Hall KV; Saady JJ Forensic Sci Int; 1993 Apr; 59(1):63-70. PubMed ID: 8099337 [TBL] [Abstract][Full Text] [Related]
9. Designer drug confusion: a focus on MDMA. Beck J; Morgan PA J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058 [No Abstract] [Full Text] [Related]
10. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Yousif MY; Fitzgerald RL; Narasimhachari N; Rosecrans JA; Blanke RV; Glennon RA Drug Alcohol Depend; 1990 Oct; 26(2):127-35. PubMed ID: 1978707 [TBL] [Abstract][Full Text] [Related]
11. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats. Matsushima K; Nagai T; Kamiyama S J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966 [TBL] [Abstract][Full Text] [Related]
12. Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland. O'Connell D; Heffron JJ Analyst; 2000 Jan; 125(1):119-21. PubMed ID: 10885070 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS. Borth S; Hänsel W; Rösner P; Junge T Forensic Sci Int; 2000 Dec; 114(3):139-53. PubMed ID: 11027867 [TBL] [Abstract][Full Text] [Related]
14. Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays. Thompson WC; Dasgupta A Clin Chem; 1994 Sep; 40(9):1703-6. PubMed ID: 7915216 [TBL] [Abstract][Full Text] [Related]
15. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329 [TBL] [Abstract][Full Text] [Related]
16. The identification of a chlorinated MDMA. Maresova V; Hampl J; Chundela Z; Zrcek F; Polasek M; Chadt J J Anal Toxicol; 2005; 29(5):353-8. PubMed ID: 16105260 [TBL] [Abstract][Full Text] [Related]
17. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Meyer MR; Peters FT; Maurer HH Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971 [TBL] [Abstract][Full Text] [Related]
18. Fingerprinting of 3, 4-methylenedioxymethamphetamine markers by desorption/ionization on porous silicon. Kraj A; Swist M; Strugała A; Parczewski A; Silberring J Eur J Mass Spectrom (Chichester); 2006; 12(4):253-9. PubMed ID: 17057282 [TBL] [Abstract][Full Text] [Related]
19. Identification of some N-hydroxylated metabolites of (+/-)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry. Dumasia MC Xenobiotica; 2003 Oct; 33(10):1013-25. PubMed ID: 14555338 [TBL] [Abstract][Full Text] [Related]
20. Potential misrepresentation of 3,4-methylenedioxyamphetamine (MDA). A toxicological warning. Shulgin AT; Jacob P J Anal Toxicol; 1982; 6(2):71-5. PubMed ID: 7098452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]